Pharmacopsychiatry

Papers
(The TQCC of Pharmacopsychiatry is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels102
Review and Consensus on Pharmacogenomic Testing in Psychiatry91
The History of Psychedelics in Psychiatry52
Psychedelics and Psychotherapy34
Classic Psychedelic Drugs: Update on Biological Mechanisms31
Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders30
Cross-Cultural Validity of Psychological Distress Measurement During the Coronavirus Pandemic30
Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports27
Candidate Psychotropics against SARS – CoV – 2: A Narrative Review23
Safety and Tolerability of the Anxiolytic and Nootropic Drug Phenibut: A Systematic Review of Clinical Trials and Case Reports19
Safety Profile of Methylphenidate Under Long-Term Treatment in Adult ADHD Patients – Results of the COMPAS Study16
Patients’ Perspectives on Psychiatric Pharmacogenetic Testing16
Opioid Mortality Following Implementation of Medical Cannabis Programs in the United States14
Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease14
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice14
Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry13
The Potential Role of Psychedelic Drugs in Mental Health Care of the Future12
Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update12
Neurotrophic Properties of Silexan, an Essential Oil from the Flowers of Lavender-Preclinical Evidence for Antidepressant-Like Properties12
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study10
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response10
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?10
COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine10
Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases9
Drug-Drug Interactions Between Lithium and Cardiovascular as Well as Anti-Inflammatory Drugs9
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs9
Potential Drug interactions with Drugs used for Bipolar Disorder: A Comparison of 6 Drug Interaction Database Programs9
Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus8
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study8
Expression Biomarkers of Pharmacological Treatment Outcomes in Women with Unipolar and Bipolar Depression8
Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression8
Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19: A Retrospective Explorative Multi-center Study from the German M7
Anti-SARS-CoV-2 Action of Fluvoxamine may be Mediated by Endothelial Nitric Oxide Synthase7
Metformin Attenuates the Metabolic Disturbance and Depression-like Behaviors Induced by Corticosterone and Mediates the Glucose Metabolism Pathway7
Sex-specific Association of Antipsychotic-induced Weight Gain and Treatment Response for Antipsychotic-Naive First Episode Schizophrenia Patients: A Prospective 8-week Longitudinal Study6
Frequencies of Genetic Polymorphisms of Clinically Relevant Gene-Drug Pairs in a German Psychiatric Inpatient Population6
Psychedelics: A New Treatment Paradigm in Psychiatry?6
0.032171010971069